Form 8-K - Current report:
SEC Accession No. 0001654954-21-001659
Filing Date
2021-02-16
Accepted
2021-02-16 07:31:09
Documents
5
Period of Report
2021-02-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT a8kpressreleaMNPRValidive.htm 8-K 32279
2 ADDITIONAL EXHIBITS validivefpi02012021.htm EX-99 19931
3 IMAGE validivefpi02012021000.jpg GRAPHIC 4281
4 IMAGE validivefpi02012021001.jpg GRAPHIC 933
5 IMAGE validivefpi02012021002.jpg GRAPHIC 916
  Complete submission text file 0001654954-21-001659.txt   62217
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 21632451
SIC: 2834 Pharmaceutical Preparations